Collects data on adults receiving stem cell transplants for blood cancers
Collects and stores data on adults undergoing stem cell transplant for blood cancers.
Key facts
- Who runs it
- Wake Forest University Health Sciences
- Where
- Winston-Salem, United StatesSee the site
- Trial code
- Registry title
- The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 21 May 2001
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 13 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are planned to have standard-care high-dose therapy followed by a bone marrow transplant, using their own cells or a donor's cells. Their data will be collected and stored.
- Age
- 18 to 120 years
- Sex
- All sexes can join.
- Earlier treatment
- The record says they must be planned for standard-of-care dose intensive therapy and either an allogeneic or autologous bone marrow transplant.
Main reasons for not taking part
- Taking part in any other treatment research protocol
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
Who cannot take part
- Participation in any other treatment research protocol
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Where in United States
- Wake Forest Baptist HealthWinston-Salem, United StatesContact: David Hurd, MDTaking people
About the trial
What the trial wants to find out
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Prospective Collection, Storage and Reporting of Data on Patients
- Plain-language title
- Collects data on adults receiving stem cell transplants for blood cancersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT01890486, who can take part
- Record updated
- 13 April 2026